Published on Monday July 27, 2015
Smooth Drug Development is initiating an international phase II study in HDVSmooth Drug Development is initiating an international phase II study in HDV. The study will be performed in 120 patients with HDV at 20 investigational sites in Russia and Germany.
Smooth Drug Development team will be managing the trial in Russia and Germany.
We maintain the principle of "one stop service" when all activities from planning to product registration are performed under the control of the one team of professionals. According to the requirements of ISO 9001:2008, in case of outsourcing of vendors we manage them and are fully responsible for the results.